Meta description: A regulatory update on a COPD inspiratory muscle training trial comparing basic IMT, functional IMT, and a control arm and its implications for device evaluation.
Publication date context: February 15, 2026. This regulatory style report summarizes a trial in chronic obstructive pulmonary disease that compares two inspiratory muscle training modalities against a control condition.
The study is sponsored by the University of Yalova and is listed on ClinicalTrials.gov under identifier NCT07406659 and shows not yet recruiting status. The target audience includes clinical, quality and regulatory teams evaluating device performance and safety in respiratory therapy.
What is being studied in this COPD inspiratory muscle training trial?
The trial focuses on adults with chronic obstructive pulmonary disease and compares two inspiratory muscle training approaches with a control group. The interventions are designed to determine whether training the inspiratory muscles yields measurable improvements in respiratory function, exercise tolerance or quality of life when compared with standard care. Details of the intervention arms are limited in the registry but they represent two distinct approaches to respiratory muscle conditioning.
Interventions are listed as Basic Inspiratory Muscle Training and Functional Inspiratory Muscle Training, with a separate control arm. The study is registered on ClinicalTrials.gov as NCT07406659 and currently not recruiting. The sponsor is the University of Yalova.
Registry details are publicly accessible at https://clinicaltrials.gov/study/NCT07406659?term=medical+device. This reference supports transparency and enables stakeholders to trace study design and status.
Which interventions are being compared?
- Basic Inspiratory Muscle Training
- Functional Inspiratory Muscle Training
- Control
These arms allow assessment of whether any training modality provides advantages over no targeted respiratory muscle intervention for people with COPD, and how the two IMT approaches compare against each other in terms of potential impact on respiratory function and patient well being.
Who sponsors the study and what is its current status?
The University of Yalova sponsors the trial. The record indicates not yet recruiting, meaning enrollment has not begun and regulatory review and registration processes may be ongoing to ensure compliance with clinical trial requirements.
What are the regulatory implications for device evaluation?
As with any device oriented study in respiratory rehabilitation, results may inform future regulatory assessments of inspiratory training devices. The study aims to generate evidence on safety and performance for basic and functional IMT technologies used in COPD management. Any conclusions will be limited to the conditions of the trial and will require further verification in broader populations before device labeling or market authorization decisions. The source does not provide manufacturer statements.
The regulatory context requires clear indication of intended use, performance claims and safety considerations, with data sourced from well designed studies such as this trial to support decision making by authorities and sponsors.
What happens next for patients and regulators?
If enrollment proceeds, investigators expect to collect data on respiratory outcomes that may influence clinical practice and device evaluation frameworks. Regulators may review outcome measures related to device performance and safety before approving or updating guidance for inspiratory training devices in COPD care. The final results will determine whether these IMT approaches become part of standard care pathways or remain investigational tools pending additional studies and confirmation in diverse patient populations.
FAQ
- 1. What is the primary aim of this trial? To compare two inspiratory muscle training modalities with a control and assess their potential benefits in COPD management.
- 2. Who funds the study? The University of Yalova sponsors the trial.
- 3. Where can I find registry details? The trial is registered on ClinicalTrials.gov with identifier NCT07406659 and page at https://clinicaltrials.gov/study/NCT07406659?term=medical+device.
Conclusion
The COPD inspiratory muscle training trial represents a regulatory focused pathway to assess two device based training approaches against a control. Findings will inform safety, performance and future regulatory considerations for IMT devices in respiratory care.
Disclaimer
Professional audience only. This is not legal advice and should not be construed as regulatory guidance. All claims must be supported by the source text and any cited regulatory standards.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07406659?term=medical+device